Postoperative Nausea and Vomiting (PONV) Market, Global Outlook and Forecast 2022-2028
The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe.
This report contains market size and forecasts of Postoperative Nausea and Vomiting (PONV) in Global, including the following market information:
Global Postoperative Nausea and Vomiting (PONV) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Postoperative Nausea and Vomiting (PONV) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Serotonin Antagonists Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Postoperative Nausea and Vomiting (PONV) include Acacia Pharma, F. Hoffmann-La Roche, Novartis, Ani Pharmaceuticals, Camurus, Sanofi, Helsinn Holding, Eisai and Merck and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Postoperative Nausea and Vomiting (PONV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Postoperative Nausea and Vomiting (PONV) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Postoperative Nausea and Vomiting (PONV) Market Segment Percentages, by Type, 2021 (%)
Global Postoperative Nausea and Vomiting (PONV) Market Segment Percentages, by Application, 2021 (%)
Global Postoperative Nausea and Vomiting (PONV) Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Postoperative Nausea and Vomiting (PONV) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Postoperative Nausea and Vomiting (PONV) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Postoperative Nausea and Vomiting (PONV) in Global, including the following market information:
Global Postoperative Nausea and Vomiting (PONV) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Postoperative Nausea and Vomiting (PONV) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Serotonin Antagonists Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Postoperative Nausea and Vomiting (PONV) include Acacia Pharma, F. Hoffmann-La Roche, Novartis, Ani Pharmaceuticals, Camurus, Sanofi, Helsinn Holding, Eisai and Merck and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Postoperative Nausea and Vomiting (PONV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Postoperative Nausea and Vomiting (PONV) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Postoperative Nausea and Vomiting (PONV) Market Segment Percentages, by Type, 2021 (%)
- Serotonin Antagonists
- Steroids
- Dopamine Antagonists
- NK-1 Receptor Antagonists
- Non-pharmacologic Treatment
- Others
Global Postoperative Nausea and Vomiting (PONV) Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Global Postoperative Nausea and Vomiting (PONV) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Postoperative Nausea and Vomiting (PONV) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Postoperative Nausea and Vomiting (PONV) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Acacia Pharma
- F. Hoffmann-La Roche
- Novartis
- Ani Pharmaceuticals
- Camurus
- Sanofi
- Helsinn Holding
- Eisai
- Merck
- GlaxoSmithKline
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Postoperative Nausea and Vomiting (PONV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Postoperative Nausea and Vomiting (PONV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) OVERALL MARKET SIZE
2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size: 2021 VS 2028
2.2 Global Postoperative Nausea and Vomiting (PONV) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Postoperative Nausea and Vomiting (PONV) Players in Global Market
3.2 Top Global Postoperative Nausea and Vomiting (PONV) Companies Ranked by Revenue
3.3 Global Postoperative Nausea and Vomiting (PONV) Revenue by Companies
3.4 Top 3 and Top 5 Postoperative Nausea and Vomiting (PONV) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Postoperative Nausea and Vomiting (PONV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Postoperative Nausea and Vomiting (PONV) Players in Global Market
3.6.1 List of Global Tier 1 Postoperative Nausea and Vomiting (PONV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Postoperative Nausea and Vomiting (PONV) Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Postoperative Nausea and Vomiting (PONV) Market Size Markets, 2021 & 2028
4.1.2 Serotonin Antagonists
4.1.3 Steroids
4.1.4 Dopamine Antagonists
4.1.5 NK-1 Receptor Antagonists
4.1.6 Non-pharmacologic Treatment
4.1.7 Others
4.2 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue & Forecasts
4.2.1 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2022
4.2.2 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2023-2028
4.2.3 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Postoperative Nausea and Vomiting (PONV) Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Retail Pharmacies
5.2 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue & Forecasts
5.2.1 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2022
5.2.2 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2023-2028
5.2.3 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Postoperative Nausea and Vomiting (PONV) Market Size, 2021 & 2028
6.2 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue & Forecasts
6.2.1 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2022
6.2.2 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2023-2028
6.2.3 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2028
6.3.2 US Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.3.3 Canada Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.3.4 Mexico Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2028
6.4.2 Germany Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4.3 France Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4.4 U.K. Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4.5 Italy Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4.6 Russia Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4.7 Nordic Countries Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4.8 Benelux Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2028
6.5.2 China Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.5.3 Japan Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.5.4 South Korea Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.5.5 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.5.6 India Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2028
6.6.2 Brazil Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.6.3 Argentina Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2028
6.7.2 Turkey Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.7.3 Israel Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.7.4 Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.7.5 UAE Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Acacia Pharma
7.1.1 Acacia Pharma Corporate Summary
7.1.2 Acacia Pharma Business Overview
7.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.1.4 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.1.5 Acacia Pharma Key News
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Corporate Summary
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.2.4 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.2.5 F. Hoffmann-La Roche Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.3.4 Novartis Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.3.5 Novartis Key News
7.4 Ani Pharmaceuticals
7.4.1 Ani Pharmaceuticals Corporate Summary
7.4.2 Ani Pharmaceuticals Business Overview
7.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.4.4 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.4.5 Ani Pharmaceuticals Key News
7.5 Camurus
7.5.1 Camurus Corporate Summary
7.5.2 Camurus Business Overview
7.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.5.4 Camurus Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.5.5 Camurus Key News
7.6 Sanofi
7.6.1 Sanofi Corporate Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.6.4 Sanofi Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.6.5 Sanofi Key News
7.7 Helsinn Holding
7.7.1 Helsinn Holding Corporate Summary
7.7.2 Helsinn Holding Business Overview
7.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.7.4 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.7.5 Helsinn Holding Key News
7.8 Eisai
7.8.1 Eisai Corporate Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.8.4 Eisai Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.8.5 Eisai Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.9.4 Merck Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.9.5 Merck Key News
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Corporate Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.10.4 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.10.5 GlaxoSmithKline Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Postoperative Nausea and Vomiting (PONV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Postoperative Nausea and Vomiting (PONV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL POSTOPERATIVE NAUSEA AND VOMITING (PONV) OVERALL MARKET SIZE
2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size: 2021 VS 2028
2.2 Global Postoperative Nausea and Vomiting (PONV) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Postoperative Nausea and Vomiting (PONV) Players in Global Market
3.2 Top Global Postoperative Nausea and Vomiting (PONV) Companies Ranked by Revenue
3.3 Global Postoperative Nausea and Vomiting (PONV) Revenue by Companies
3.4 Top 3 and Top 5 Postoperative Nausea and Vomiting (PONV) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Postoperative Nausea and Vomiting (PONV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Postoperative Nausea and Vomiting (PONV) Players in Global Market
3.6.1 List of Global Tier 1 Postoperative Nausea and Vomiting (PONV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Postoperative Nausea and Vomiting (PONV) Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Postoperative Nausea and Vomiting (PONV) Market Size Markets, 2021 & 2028
4.1.2 Serotonin Antagonists
4.1.3 Steroids
4.1.4 Dopamine Antagonists
4.1.5 NK-1 Receptor Antagonists
4.1.6 Non-pharmacologic Treatment
4.1.7 Others
4.2 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue & Forecasts
4.2.1 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2022
4.2.2 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2023-2028
4.2.3 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Postoperative Nausea and Vomiting (PONV) Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Retail Pharmacies
5.2 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue & Forecasts
5.2.1 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2022
5.2.2 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2023-2028
5.2.3 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Postoperative Nausea and Vomiting (PONV) Market Size, 2021 & 2028
6.2 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue & Forecasts
6.2.1 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2022
6.2.2 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2023-2028
6.2.3 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2028
6.3.2 US Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.3.3 Canada Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.3.4 Mexico Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2028
6.4.2 Germany Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4.3 France Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4.4 U.K. Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4.5 Italy Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4.6 Russia Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4.7 Nordic Countries Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.4.8 Benelux Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2028
6.5.2 China Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.5.3 Japan Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.5.4 South Korea Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.5.5 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.5.6 India Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2028
6.6.2 Brazil Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.6.3 Argentina Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2028
6.7.2 Turkey Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.7.3 Israel Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.7.4 Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
6.7.5 UAE Postoperative Nausea and Vomiting (PONV) Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Acacia Pharma
7.1.1 Acacia Pharma Corporate Summary
7.1.2 Acacia Pharma Business Overview
7.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.1.4 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.1.5 Acacia Pharma Key News
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Corporate Summary
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.2.4 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.2.5 F. Hoffmann-La Roche Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.3.4 Novartis Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.3.5 Novartis Key News
7.4 Ani Pharmaceuticals
7.4.1 Ani Pharmaceuticals Corporate Summary
7.4.2 Ani Pharmaceuticals Business Overview
7.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.4.4 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.4.5 Ani Pharmaceuticals Key News
7.5 Camurus
7.5.1 Camurus Corporate Summary
7.5.2 Camurus Business Overview
7.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.5.4 Camurus Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.5.5 Camurus Key News
7.6 Sanofi
7.6.1 Sanofi Corporate Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.6.4 Sanofi Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.6.5 Sanofi Key News
7.7 Helsinn Holding
7.7.1 Helsinn Holding Corporate Summary
7.7.2 Helsinn Holding Business Overview
7.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.7.4 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.7.5 Helsinn Holding Key News
7.8 Eisai
7.8.1 Eisai Corporate Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.8.4 Eisai Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.8.5 Eisai Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.9.4 Merck Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.9.5 Merck Key News
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Corporate Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.10.4 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2017-2022)
7.10.5 GlaxoSmithKline Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Postoperative Nausea and Vomiting (PONV) Market Opportunities & Trends in Global Market
Table 2. Postoperative Nausea and Vomiting (PONV) Market Drivers in Global Market
Table 3. Postoperative Nausea and Vomiting (PONV) Market Restraints in Global Market
Table 4. Key Players of Postoperative Nausea and Vomiting (PONV) in Global Market
Table 5. Top Postoperative Nausea and Vomiting (PONV) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Postoperative Nausea and Vomiting (PONV) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Postoperative Nausea and Vomiting (PONV) Product Type
Table 9. List of Global Tier 1 Postoperative Nausea and Vomiting (PONV) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Postoperative Nausea and Vomiting (PONV) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Postoperative Nausea and Vomiting (PONV) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Postoperative Nausea and Vomiting (PONV) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Postoperative Nausea and Vomiting (PONV) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Postoperative Nausea and Vomiting (PONV) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2023-2028
Table 30. Acacia Pharma Corporate Summary
Table 31. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 32. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche Corporate Summary
Table 34. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 35. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 38. Novartis Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 39. Ani Pharmaceuticals Corporate Summary
Table 40. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 41. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 42. Camurus Corporate Summary
Table 43. Camurus Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 44. Camurus Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi Corporate Summary
Table 46. Sanofi Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 47. Sanofi Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 48. Helsinn Holding Corporate Summary
Table 49. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 50. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 51. Eisai Corporate Summary
Table 52. Eisai Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 53. Eisai Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 54. Merck Corporate Summary
Table 55. Merck Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 56. Merck Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 57. GlaxoSmithKline Corporate Summary
Table 58. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 59. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 1. Postoperative Nausea and Vomiting (PONV) Market Opportunities & Trends in Global Market
Table 2. Postoperative Nausea and Vomiting (PONV) Market Drivers in Global Market
Table 3. Postoperative Nausea and Vomiting (PONV) Market Restraints in Global Market
Table 4. Key Players of Postoperative Nausea and Vomiting (PONV) in Global Market
Table 5. Top Postoperative Nausea and Vomiting (PONV) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Postoperative Nausea and Vomiting (PONV) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Postoperative Nausea and Vomiting (PONV) Product Type
Table 9. List of Global Tier 1 Postoperative Nausea and Vomiting (PONV) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Postoperative Nausea and Vomiting (PONV) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Postoperative Nausea and Vomiting (PONV) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Postoperative Nausea and Vomiting (PONV) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Postoperative Nausea and Vomiting (PONV) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Postoperative Nausea and Vomiting (PONV) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2023-2028
Table 30. Acacia Pharma Corporate Summary
Table 31. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 32. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche Corporate Summary
Table 34. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 35. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 38. Novartis Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 39. Ani Pharmaceuticals Corporate Summary
Table 40. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 41. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 42. Camurus Corporate Summary
Table 43. Camurus Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 44. Camurus Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi Corporate Summary
Table 46. Sanofi Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 47. Sanofi Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 48. Helsinn Holding Corporate Summary
Table 49. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 50. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 51. Eisai Corporate Summary
Table 52. Eisai Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 53. Eisai Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 54. Merck Corporate Summary
Table 55. Merck Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 56. Merck Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
Table 57. GlaxoSmithKline Corporate Summary
Table 58. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 59. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Postoperative Nausea and Vomiting (PONV) Segment by Type in 2021
Figure 2. Postoperative Nausea and Vomiting (PONV) Segment by Application in 2021
Figure 3. Global Postoperative Nausea and Vomiting (PONV) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Postoperative Nausea and Vomiting (PONV) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue in 2021
Figure 8. By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 12. US Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 16. Germany Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 17. France Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 24. China Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 28. India Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 30. Brazil Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 33. Turkey Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 37. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Camurus Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eisai Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Merck Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Postoperative Nausea and Vomiting (PONV) Segment by Type in 2021
Figure 2. Postoperative Nausea and Vomiting (PONV) Segment by Application in 2021
Figure 3. Global Postoperative Nausea and Vomiting (PONV) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Postoperative Nausea and Vomiting (PONV) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Postoperative Nausea and Vomiting (PONV) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue in 2021
Figure 8. By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 12. US Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 16. Germany Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 17. France Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 24. China Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 28. India Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 30. Brazil Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2017-2028
Figure 33. Turkey Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2017-2028
Figure 37. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Camurus Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eisai Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Merck Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
